News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The average 12-month price target for Prime Medicine, Inc. (PRME) stock has been lowered from $7.12 to $6.92 by 9 analysts, yet this new target still suggests a significant 124% potential upside from its August 14th closing price. The consensus rating for PRME remains …
PrimeEnergy (NASDAQ:PNRG) reported its quarterly earnings, posting an EPS of $2.75, significantly missing the consensus estimate of $5.90 by $3.15. Despite the earnings miss, the stock saw a slight increase of $5.39 to $200.98 on Friday, though trading volume was below average. Analyst sentiment …
Algorhythm Holdings (NASDAQ: MICS) reported a net loss of $4.1 million for Q2 2026, or $0.25 per share, an increase from the $0.24 loss per share in Q2 2025, due to heavy investment in growth. Despite the widening loss, revenue surged by 161% to …
WindAcre Partnership, its Master Fund, and Snehal Rajnikant Amin have filed an amended Schedule 13G/A, reporting a beneficial ownership of 9.9% in Perimeter Solutions Inc. (PRM). This stake comprises 16,148,621 shares of common stock, with shared voting and dispositive power. The ownership percentage is …
PrimeEnergy Resources (NASDAQ: PNRG) reported a Q2 2026 net income of $6.5 million, up from $3.2 million in the prior year, despite its first-half net income declining to $10.9 million from $12.4 million in 2025. The company benefited from a strong average realized oil …
Algorhythm Holdings Inc has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters and republished on TradingView News, provides an overview of the company's financial performance during this period. Readers can access the full report and …
Algorhythm Holdings (NASDAQ: RIME) reported Q2 2026 EPS of $(0.25), significantly beating the $(0.36) analyst consensus. Revenue reached $3.005 million, exceeding estimates by 0.17% and representing a 161% year-over-year increase, driven by strategic expansions in North America and India. Despite top-line growth, the company's …
Algorhythm Holdings, Inc. (RIME) reported its Q2 2026 financial results, with revenue increasing to $3.01 million and a net loss of $(3.83) million, resulting in a diluted loss per share of $(0.25). This growth was largely due to the acquisition of SMCB and the …
Perimeter Acquisition Corp. I (PMTR), a Cayman Islands SPAC, reported net income of $3.43 million for the first half of 2026, primarily from $4.32 million in interest earned on its trust account. The company, which has not yet found a business combination target, disclosed …
Kayne Anderson Rudnick Investment Management, LLC has reported a beneficial ownership of 2,768,786 shares in Primerica, Inc., representing 8.9% of the company's common stock as of June 30, 2026. This filing indicates that Kayne Anderson Rudnick is a significant institutional shareholder, possessing both sole …
Perimeter Solutions (PRM) stock fell 17.8% after its latest earnings report, despite increases in adjusted EBITDA and net sales year-over-year. The market is reassessing the company's valuation due to execution risks, contract timing sensitivity, and a temporary pause in DLA foam deliveries impacting near-term …
Zacks Research has downgraded Perimeter Solutions (NYSE:PRM) from a "hold" to a "strong sell" rating. This downgrade comes despite a broader "Moderate Buy" consensus among other analysts, with an average price target of $41.75. The company recently missed quarterly earnings and revenue estimates, and …
HC Wainwright has revised its Q3 2026 EPS estimate for Prime Medicine (NASDAQ: PRME) to a loss of $0.28 per share, a slight improvement from the previous forecast of $0.29. Despite maintaining a "Buy" rating and an $8.00 price target, analysts still anticipate the …
Primerica Inc (PRI) Director Amber Cottle sold 279 shares of the company stock, valued at approximately $87,503. This sale aligns with a broader trend of insider selling at Primerica over the past year, with 12 insider sells and no buys. Despite the selling activity, …
KBW has increased its target price for Primerica, Inc. (PRI) to $335 from $323. This update was reported by Reuters on August 11, 2026. The article itself is a brief announcement without further details on the rationale behind the target price adjustment.
Search by ticker symbol or company name and select a result to open its chart.